BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14674508)

  • 1. The use of stratefied sampling of blend and dosage units to demonstrate adequacy of mix for powder blends.
    Boehm G; Clark J; Dietrick J; Foust L; Garcia T; Gavini M; Gelber L; Geoffroy JM; Hoblitzell J; Jimenez P; Mergen G; Muzzio F; Planchard J; Prescott J; Timmermans J; Takiar N
    PDA J Pharm Sci Technol; 2003; 57(2):64-74. PubMed ID: 14674508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of blend uniformity and content uniformity based on 2003 stratified sampling guidance and 1999 blend uniformity analysis guidance: product A.
    Howard-Sparks M; Gawlikowski A;
    PDA J Pharm Sci Technol; 2004; 58(4):222-30. PubMed ID: 15368992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Results of statistical analysis of blend and dosage unit content uniformity data obtained from the Product Quality Research Institute Blend Uniformity Working Group data-mining effort.
    Boehm G; Clark J; Dietrick J; Foust L; Garcia T; Gavini M; Geoffroy JM; Jimenez P; Mergen G; Muzzio F; Planchard J; Prescott J; Timmermans J; Takiar N; Whiteman D;
    PDA J Pharm Sci Technol; 2004; 58(2):62-74. PubMed ID: 15113072
    [No Abstract]   [Full Text] [Related]  

  • 4. Quality assurance test of delivered dose uniformity of multiple-dose inhaler and dry powder inhaler drug products.
    Tsong Y; Dong X; Shen M; Lostritto RT
    J Biopharm Stat; 2015; 25(2):328-38. PubMed ID: 25357132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How do formulation and process parameters impact blend and unit dose uniformity? Further analysis of the product quality research institute blend uniformity working group industry survey.
    Hancock BC; Garcia-Munoz S
    J Pharm Sci; 2013 Mar; 102(3):982-6. PubMed ID: 23280670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The compliance and science of Blend Uniformity Analysis.
    Berman J
    PDA J Pharm Sci Technol; 2001; 55(4):209-22. PubMed ID: 11505553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blend uniformity analysis: validation and in-process testing. Technical Report No. 25. PDA (Parenteral Drug association).
    Berman J; Elinski DE; Gonzales CR; Hofer JD; Jimenez PJ; Planchard JA; Tlachac RJ; Vogel PF
    PDA J Pharm Sci Technol; 1997; 51 Suppl 3():i-iii, S1-99. PubMed ID: 9448437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Near-infrared spectroscopy and imaging for the monitoring of powder blend homogeneity.
    El-Hagrasy AS; Morris HR; D'Amico F; Lodder RA; Drennen JK
    J Pharm Sci; 2001 Sep; 90(9):1298-307. PubMed ID: 11745782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blend uniformity analysis of pharmaceutical products by Broadband Acoustic Resonance Dissolution Spectroscopy (BARDS).
    Fitzpatrick D; Scanlon E; Krüse J; Vos B; Evans-Hurson R; Fitzpatrick E; McSweeney S
    Int J Pharm; 2012 Nov; 438(1-2):134-9. PubMed ID: 22884840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Discrete element method (DEM) simulations of stratified sampling during solid dosage form manufacturing.
    Hancock BC; Ketterhagen WR
    Int J Pharm; 2011 Oct; 418(2):265-72. PubMed ID: 21635943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FDA pharmaceutical quality oversight.
    Yu LX; Woodcock J
    Int J Pharm; 2015 Aug; 491(1-2):2-7. PubMed ID: 26027494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Real time monitoring of powder blend bulk density for coupled feed-forward/feed-back control of a continuous direct compaction tablet manufacturing process.
    Singh R; Román-Ospino AD; Romañach RJ; Ierapetritou M; Ramachandran R
    Int J Pharm; 2015 Nov; 495(1):612-625. PubMed ID: 26386140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory and quality considerations for continuous manufacturing. May 20-21, 2014 Continuous Manufacturing Symposium.
    Allison G; Cain YT; Cooney C; Garcia T; Bizjak TG; Holte O; Jagota N; Komas B; Korakianiti E; Kourti D; Madurawe R; Morefield E; Montgomery F; Nasr M; Randolph W; Robert JL; Rudd D; Zezza D
    J Pharm Sci; 2015 Mar; 104(3):803-12. PubMed ID: 25830179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The development of a blend-sampling technique to assess the uniformity of a powder mixture.
    Garcia TP; Wilkinson SJ; Scott JF
    Drug Dev Ind Pharm; 2001 Apr; 27(4):297-307. PubMed ID: 11411897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of process parameters on content uniformity of a low dose active pharmaceutical ingredient in a tablet formulation according to GMP.
    Muselík J; Franc A; Doležel P; Goněc R; Krondlová A; Lukášová I
    Acta Pharm; 2014 Sep; 64(3):355-67. PubMed ID: 25296681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the performance of two sample thieves for the determination of the content uniformity of a powder blend.
    Garcia TP; Taylor MK; Pande GS
    Pharm Dev Technol; 1998 Feb; 3(1):7-12. PubMed ID: 9532595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing Product Quality: a Summary of the Second FDA/PQRI Conference.
    Yu LX; Akseli I; Allen B; Amidon G; Bizjak TG; Boam A; Caulk M; Doleski D; Famulare J; Fisher AC; Furness S; Hasselbalch B; Havel H; Hoag SW; Iser R; Johnson BD; Ju R; Katz P; Lacana E; Lee SL; Lostritto R; McNally G; Mehta M; Mohan G; Nasr M; Nosal R; Oates M; O'Connor T; Polli J; Raju GK; Ramanadham M; Randazzo G; Rosencrance S; Schwendeman A; Selen A; Seo P; Shah V; Sood R; Thien MP; Tong T; Trout BL; Tyner K; Vaithiyalingam S; VanTrieste M; Walsh F; Wesdyk R; Woodcock J; Wu G; Wu L; Yu L; Zezza D
    AAPS J; 2016 Mar; 18(2):528-43. PubMed ID: 26860627
    [No Abstract]   [Full Text] [Related]  

  • 18. Cohesive, multicomponent, dense powder flow characterization by NIR.
    Benedetti C; Abatzoglou N; Simard JS; McDermott L; Léonard G; Cartilier L
    Int J Pharm; 2007 May; 336(2):292-301. PubMed ID: 17240094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adequacy and verifiability of pharmaceutical mixtures and dose units by variographic analysis (Theory of Sampling) - A call for a regulatory paradigm shift.
    Esbensen KH; Román-Ospino AD; Sanchez A; Romañach RJ
    Int J Pharm; 2016 Feb; 499(1-2):156-174. PubMed ID: 26707245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PQRI recommendations on particle-size analysis of drug substances used in oral dosage forms.
    Snorek SM; Bauer JF; Chidambaram N; Doub WH; Duffy EP; Etzler FM; Kelly RN; Lane JJ; Mueller RL; Prasanna HR; Pujara CP; Reif VD; Scarlett B; Stowell JG; Toma PH
    J Pharm Sci; 2007 Jun; 96(6):1451-67. PubMed ID: 17238204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.